Viatris Inc. (VTRS) P/E Ratio History
Deep ValueTrading at -5.1x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2014–2023
Loading P/E history...
P/E Ratio Analysis
As of June 22, 2026, Viatris Inc. (VTRS) trades at a price-to-earnings ratio of -5.1x, with a stock price of $15.37 and trailing twelve-month earnings per share of $-0.25.
The current P/E is 105% below its 5-year average of 99.8x. Over the past five years, VTRS's P/E has ranged from a low of 6.1x to a high of 644.2x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.1x, VTRS trades at a 123% discount to its sector peers. The sector includes 234 companies with P/E ratios ranging from 0.0x to 197.0x.
Relative to the broader market, VTRS trades at a notable discount to the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our VTRS DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
VTRS Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
VTRS P/E vs Peers
Large-scale generic drug manufacturers peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $37B | 26.2 | - | +183%Best | |
| $5B | 73.7 | - | +158% | |
| $143B | 18.5 | - | -4% | |
| $281B | 15.6 | 0.74Best | +8% | |
| $383B | 91.4 | - | -1% | |
| $65M | 11.0Lowest | - | +104% | |
| $90B | 19.6 | - | +49% | |
| $52B | 34.4 | - | +87% | |
| $125B | 70.7 | - | -62% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
VTRS Historical P/E Data (2014–2023)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2023 Q4 | Dec 31 2023 | $10.83 | $0.04 | 270.8x | +275% |
| FY2023 Q3 | Sep 30 2023 | $9.86 | $1.51 | 6.5x | -91% |
| FY2023 Q2 | Jun 30 2023 | $9.98 | $1.53 | 6.5x | -91% |
| FY2023 Q1 | Mar 31 2023 | $9.62 | $1.57 | 6.1x | -92% |
| FY2022 Q4 | Dec 31 2022 | $11.13 | $1.71 | 6.5x | -91% |
| FY2022 Q3 | Sep 30 2022 | $8.52 | $0.66 | 12.9x | -82% |
| FY2022 Q2 | - | $10.47 | $0.63 | 16.6x | -77% |
| FY2022 Q1 | - | $10.88 | $0.14 | 77.7x | +8% |
| FY2020 Q3 | Sep 27 2020 | $14.42 | $0.52 | 28.0x | -61% |
| FY2020 Q2 | Jun 28 2020 | $15.89 | $0.53 | 30.2x | -58% |
| FY2020 Q1 | Mar 29 2020 | $14.88 | $0.12 | 124.3x | +72% |
| FY2019 Q4 | - | $20.10 | $0.03 | 644.2x | +792% |
| FY2019 Q3 | Sep 29 2019 | $19.29 | $0.09 | 212.0x | +193% |
| FY2019 Q2 | Jun 29 2019 | $19.04 | $0.06 | 312.1x | +332% |
| FY2019 Q1 | Mar 30 2019 | $28.34 | $0.46 | 61.5x | -15% |
| FY2018 Q4 | Dec 30 2018 | $27.27 | $0.68 | 40.1x | -44% |
| FY2018 Q3 | Sep 29 2018 | $36.60 | $1.04 | 35.2x | -51% |
| FY2018 Q2 | Jun 29 2018 | $36.14 | $0.86 | 42.0x | -42% |
| FY2018 Q1 | Mar 30 2018 | $41.17 | $1.34 | 30.7x | -57% |
| FY2017 Q4 | Dec 30 2017 | $42.31 | $1.29 | 32.8x | -55% |
| FY2017 Q3 | Sep 29 2017 | $31.37 | $1.61 | 19.5x | -73% |
| FY2017 Q2 | - | $38.76 | $1.22 | 31.8x | -56% |
| FY2017 Q1 | - | $39.59 | $1.00 | 39.6x | -45% |
| FY2016 Q4 | Dec 30 2016 | $38.15 | $0.91 | 42.0x | -42% |
| FY2016 Q3 | - | $38.47 | $0.51 | 75.8x | +5% |
| FY2016 Q2 | Jun 29 2016 | $43.22 | $1.57 | 27.6x | -62% |
| FY2016 Q1 | Mar 30 2016 | $46.40 | $1.56 | 29.8x | -59% |
| FY2015 Q4 | Dec 30 2015 | $54.62 | $1.66 | 32.9x | -54% |
| FY2015 Q3 | - | $39.80 | $1.75 | 22.7x | -69% |
| FY2015 Q2 | Jun 29 2015 | $67.63 | $2.18 | 31.0x | -57% |
| FY2015 Q1 | Mar 30 2015 | $60.00 | $2.18 | 27.5x | -62% |
| FY2014 Q4 | - | $56.94 | $2.34 | 24.3x | -66% |
| FY2014 Q3 | Sep 29 2014 | $45.79 | $2.32 | 19.7x | -73% |
| FY2014 Q2 | Jun 29 2014 | $51.51 | $1.46 | 35.3x | -51% |
Average P/E for displayed period: 72.2x
Full Stock Analysis
Deep dive into VTRS consensus models and risk factors.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
12+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
VTRS — Frequently Asked Questions
Quick answers to the most common questions about buying VTRS stock.
What is VTRS's P/E ratio?
Viatris Inc. (VTRS) trailing twelve-month P/E ratio is -5.1x, based on TTM diluted EPS of $-0.25. The 5-year average P/E is 99.8x and the historical range spans 6.1x to 644.2x.
Is VTRS stock overvalued or undervalued?
VTRS trades at -5.1x P/E, below its 5-year average of 99.8x. At the 0th percentile of its historical range (6.1x–644.2x), the stock is priced at a discount to its own history.
Is VTRS stock expensive?
No, VTRS is not expensive on a historical basis. The current P/E of -5.1x is below the 5-year average of 99.8x and sits at the 0th percentile of its valuation range.
What is VTRS's historical P/E range?
Over the past 5 years, VTRS's P/E ratio has ranged from 6.1x to 644.2x, with a median of 35.2x and an average of 99.8x. The current P/E of -5.1x places the stock at the 0th percentile of this range. Full historical data spans 2014–2023.
How does VTRS's P/E compare to the S&P 500?
VTRS trades at -5.1x P/E versus the S&P 500 median of 24.4x. The 121% discount to the market suggests lower growth expectations or perceived higher risk.
How does VTRS's valuation compare to Healthcare peers?
Viatris Inc. P/E of -5.1x compares to the Healthcare sector median of 22.1x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is VTRS's PEG ratio?
VTRS PEG ratio is N/A, based on a P/E of -5.1x and EPS growth of -466.0%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is VTRS's earnings yield?
VTRS earnings yield is N/A, the inverse of its -5.1x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.